| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.0M | +3.5% |
| Cost of Revenue | $90.0M | +78.1% |
| R&D Expense | $152.7M | -48.3% |
| SG&A Expense | $125.5M | -28.2% |
| Operating Income | -$376.6M | +29.1% |
| Pre-tax Income | -$346.7M | +30.9% |
| Income Tax | $74K | -83.7% |
| Net Income | -$346.7M | +31.0% |
| EPS (Basic) | -$13.89 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $178.6M | -17.6% |
| Short-term Investments | $384.6M | -41.5% |
| Current Assets | $627.9M | -34.0% |
| Total Assets | $961.2M | -18.5% |
| Current Liabilities | $150.0M | -19.2% |
| Total Liabilities | $638.9M | -5.2% |
| Stockholders' Equity | $322.3M | -36.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$352.7M | +21.3% |
| Capital Expenditures | $121.9M | +175.0% |
| Investing Cash Flow | $175.7M | +251.1% |
| Financing Cash Flow | $134.3M | -71.7% |
| Free Cash Flow | -$474.6M | +3.6% |
| -832.2% |
| EPS (Diluted) | -$13.89 | -832.2% |